What the FDA labels say about taking them together
Cyclosporine and elbasvir/grazoprevir
Elbasvir/grazoprevir's FDA label of March 13, 2026 names cyclosporine in its contraindications section; the cyclosporine labels PlainMeds reads (4) do not name elbasvir/grazoprevir.
Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the elbasvir/grazoprevir FDA label on DailyMed (effective March 13, 2026, Merck Sharp & Dohme LLC).
What does the cyclosporine label say about elbasvir/grazoprevir?
Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name elbasvir/grazoprevir in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed
What does the elbasvir/grazoprevir label say about cyclosporine?
Elbasvir/grazoprevir label, contraindicationsNamed in a table that the FDA label file prints without its column breaks; the full label shows the table.
Source: FDA drug label (ZEPATIER), Merck Sharp & Dohme LLC, effective March 13, 2026 (SPL set 164dc02a-9180-426a-b8b5-04ab39d2bbd4), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Cyclosporine | Elbasvir/grazoprevir | |
|---|---|---|
| Labeled for | Organ transplant rejection, Rheumatoid arthritis | Hepatitis C |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $1.04 per unit 0.05% eye emulsion | n/a |
| Shortage now | No current entry | A presentation being discontinued |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once